Hamlet Pharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Catharina Svanborg | 50,13 | 83,45 | 2022-03-31 |
| Nordnet Pensionsförsäkring | 4,73 | 1,12 | 2022-03-31 |
| Avanza Pension | 4,60 | 1,17 | 2022-03-31 |
| Hans Nygren | 1,80 | 0,43 | 2022-03-31 |
| Rolf Karlsson | 1,78 | 0,61 | 2022-03-31 |
| Livförsäkringsbolaget Skandia | 0,80 | 0,20 | 2022-03-31 |
| Olle Jönsson | 0,63 | 0,15 | 2022-03-31 |
| Fredrik Herslow | 0,43 | 0,19 | 2022-03-31 |
| Swedbank Försäkring | 0,41 | 0,10 | 2022-03-31 |
| Creative Invest One AB | 0,37 | 0,09 | 2022-03-31 |
2022-08-26 Bokslutskommuniké 2022
2022-11-11 Delårsrapport 2023-Q1
2022-11-24 Årsstämma 2022